期刊文献+

国际资深专家谈抗精神病药物治疗的新进展 被引量:4

下载PDF
导出
摘要 本文根据2003年9月25日国际电话电视会议关于"抗精神病药物治疗新进展(New Developments In Antipsychotic Therapy) "主要内容的译文而择编的。该次会议由来自纽约州立大学精神科的Weiden PJ主持,参加会谈者有Fleischhacker WW(奥地利因斯布鲁克大学精神科诊所)、Kane JM(纽约,Hillside医院精神科)、Marder SR(加利弗尼亚,洛衫矶西部复退军人医学中心精神科)、Ryen JM(罗切斯特,Monore社区医院)和Strakowski SM(俄亥俄,辛辛那提大学精神科)。上述国际著名专家的一些观点,代表了他们各自的看法,仅供国内同道参考。
作者 朱紫青
出处 《上海精神医学》 2005年第B09期79-80,共2页 Shanghai Archives of Psychiatry
  • 相关文献

参考文献10

  • 1Fleischhacker WW. New developments in the pharmacotherapy of schizophrenia. J Neural Transm Suppl 2003;64:105-117.
  • 2Potkin SG, Saha AR, Kujawa MJ, et al. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 2003;60:681-690.
  • 3Baker RW, Kinon B J, Maguire GA, et al. Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation. J Clin Psychopharmacol2003;23:342-348.
  • 4Casey DE, Daniel DG, Wassef AA, et al. Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia. Neuropsychopharmacology 2003;28:182-192.
  • 5Kane JM, Carson WH, Saha AR, et al. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. J Clin Psychiatry 2002;63:763-771.
  • 6Lieberman J, Carson WH, Saha AR, et al. Meta-analysis of the efficacyof aripiprazole in schizophrenia. Int J Neuropsychopharmacol 2002;5(suppl 1):S186mania associated with bipolar disorder (STAMP 1 and STAMP 2). In: New Research Abstracts of the 156th Annual Meeting of the American Psychiatric Association; May 20, 2003; San Francisco, Calif.Abstract NR432:162.
  • 7Carson WH, Pigott TA, Saha AR, et al. Aripiprazole vs. placebo in the treatment of chronic schizophrenia [poster]. Presented at the 42nd annual meeting of the New Clinical Drug Evaluation Unit; June 10-13, 2002; Boca Raton, Fla.
  • 8Marder SR, Essock SM, Miller AL, et al. The Mount Sinai conference on the pharmacotherapy of schizophrenia. Schizophr Bull 2002;28:5-16.
  • 9Leucht S, Barnes TRE, Kissling W, et al. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized-controlled trials. Am J Psychiatry 2003;160:1209-1222.
  • 10Fleischhacker WW, Eerdekens M, Karcher K, et al. Treatment of schizophrenia with long-acting injectable risperidone: a 12-month evaluation of the first long-acting second-generation antipsychotic. J Clin Psychiatry 2003 ;64:1250-1257.

同被引文献40

引证文献4

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部